on-site brochure

Transcription

on-site brochure
the MICHIGAN SOCIETY of
THORACIC & CARDIOVASCULAR
SURGEONS
51st ANNUAL SUMMER MEETING
ON-SITE BROCHURE
BOYNE
MOUNTAIN
RESORT
BOYNE FALLS, MICHIGAN
AUGUST 11TH -14TH, 2016
PHONE: 517.252.4234 OR EMAIL: [email protected] OR VISIT WWW.MSTCVS.ORG
mscvts booklet.indd 1
8/2/2016 1:25:02 PM
Michigan Society of
Thoracic & Cardiovascular SurgeonS
presidential history
1965 .......................................................................................................................................... Cameron Haight, MD
1966........................................................................................................................................... Cameron Haight, MD
1967........................................................................................................................................... Cameron Haight, MD
1968..................................................................................................................................................Paul O’Rourke, MD
1969..................................................................................................................................................Paul O’Rourke, MD
1970...................................................................................................................................... Richard Rasmussen, MD
1971...................................................................................................................................................... Conrad Lam, MD
1972...................................................................................................................................... Richard Rasmussen, MD
1973...................................................................................................................................... Richard Rasmussen, MD
1974................................................................................................................................................. Rodman Taber, MD
1975............................................................................................................................................... Forest Dodrill, MD
1976................................................................................................................................................. Rodman Taber, MD
1977................................................................................................................................................. Rodman Taber, MD
1978................................................................................................................................................. Rodman Taber, MD
1979................................................................................................................................................. Rodman Taber, MD
1980................................................................................................................................................. Rodman Taber, MD
1981................................................................................................................................................... Jack Hertzler, MD
1982........................................................................................................................................... Robert Harrison, MD
1983........................................................................................................................................... Robert Harrison, MD
1984.................................................................................................................................................. Joseph Morris, MD
1985...................................................................................................................................................... Joseph Lewis, MD
1986...................................................................................................................................................... Joseph Lewis, MD
1987...................................................................................................................................................... Luis Tomatis, MD
1988...................................................................................................................................................... Luis Tomatis, MD
1989.........................................................................................................................................................Otto Gago, MD
1990.................................................................................................................................Allen Silbergleit, MD, PhD
1991.................................................................................................................................................... Marvin Kirsh, MD
1992...................................................................................................................................................... Moufi Mitri, MD
1993......................................................................................................................................... Robert Porter, Jr., MD
1994............................................................................................................................................... Agustin Arbulu, MD
1995...................................................................................................................................................... Joseph Lewis, MD
1996........................................................................................................................................... Lawrence Patzelt, MD
1997..............................................................................................................................................Richard Prager, MD
1998...................................................................................................................................Shahrokh Mansoori, MD
1999...................................................................................................................................Shahrokh Mansoori, MD
2000.................................................................................................................................................. Daniel Drake, MD
2001................................................................................................................................................... Daniel Drake, MD
2002................................................................................................................................................... Ingida Asfaw, MD
2003................................................................................................................................................... Ingida Asfaw, MD
2004................................................................................................................................................. Joseph Bassett, MD
2005................................................................................................................................................. Joseph Bassett, MD
2006....................................................................................................................................... Frederick Armenti, MD
2007....................................................................................................................................... Frederick Armenti, MD
2008............................................................................................................................................J. Charles Heiser, MD
2009............................................................................................................................................J. Charles Heiser, MD
2010..................................................................................................................................................... Eric Hanson, MD
2011...................................................................................................................................................... Eric Hanson, MD
2012................................................................................................................................................... Timothy Sell, MD
2013.....................................................................................................................................................Timothy Sell, MD
2014...............................................................................................................................................C. Douglas Lees, MD
2015...............................................................................................................................................C. Douglas Lees, MD
2016............................................................................................................................................... Alonso Collar, MD
mscvts booklet.indd 2
2
8/2/2016 1:25:02 PM
Michigan Society of
Thoracic & Cardiovascular SurgeonS
2014-2016 MSTCVS Board of Directors
Alonso Collar, MD
President
2015-2018
Robert N. Jones, MD
President Elect
2015-2018
Shahrokh Mansoori, MD
Secretary-Treasurer
2014-2016
C. Doulgas Lees, MD
Immediate Past President
2015-2018
Reza Dabir, MD
Councilor 2014-2017
Daniel Drake, MD
Councilor 2013-2016
Steve Harrington, MD
Councilor 2013-2016
Charles Schwartz, MD
Councilor 2014-2017
Gaetano Paone, MD
Councilor 2014-2017
Robert Welsh, MD
Councilor 2013-2016
Frederick R. Armenti, MD
MSMS Committee on Health Care Quality,
Efficiency & Economics Representative
Richard L. Prager, MD
Peer Review & Quality Initiative Committee Chair
Allen Silbergleit, MD, PhD
Historian & MSMS Delegate
Cindy Wikstrom
Executive Director
mscvts booklet.indd 3
3
8/2/2016 1:25:02 PM
Letter from the President
Dear Colleagues,
It is my privilege to welcome all of you to a “Pure Michigan” mid-summer meeting.
This is our society’s 51st meeting. The Michigan Society of Thoracic and
Cardiovascular Surgeons, our Quality Collaborative Committee, and the Michigan
Perfusion Society are all gathered, to once again promote “excellence” which has
been our longstanding tradition.
This year our president’s banquet will be held on Friday evening, a time when
most of us will be able to attend. This promises to be a fun evening of food, drink,
and entertainment geared to all ages! A special appearance by a comic illusionist
brings us Las Vegas style entertainment. This will be followed by Tunes by T, DJ
entertainment, for your dancing pleasure! Bring your families and share some fun.
Friday, August 12 starts promptly at 6:00.
This year’s scientific program will feature a mini-aortic symposium, a critical care
update, and controversial topics in thoracic surgery. This will of course be
coupled with actionable performance data from our Quality collaborative
committee and the Perform dataset. Our meetings always offer generous CME’s
with superb speakers in a relaxed atmosphere.
I again welcome you to share some pleasant, memorable, and worthwhile days
with your colleagues over the weekend.
Fraternally yours,
Alonso Collar M.D.
President
Michigan Society of Thoracic and Cardiovascular Surgeons
4
mscvts booklet.indd 4
8/2/2016 1:25:03 PM
MSTCVS 2016 ON-SITE BROCHURE
Table of Contents
PRESIDENTIAL HISTORY.............................................................................. 2
BOARD OF DIRECTORS................................................................................. 3
LETTER FROM THE PRESIDENT..................................................................4
BRIEF HISTORY OF MSTCVS..................................................................8 & 9
SIR MAGDI YACOUB LECTURE................................................................... 10
RODMAN TABER LECTURE......................................................................... 10
SUMMER MEETING AGENDA.................................................................. 11-14
EXHIBITORS LIST...........................................................................................15
EXHIBITORS DIAGRAM................................................................................15
SPEAKERS................................................................................................... 18-22
RESIDENTS.................................................................................................23-27
NOTES......................................................................................................16 & 17
MAP OF FACILITY .........................................................INSIDE BACK PAGE
5
mscvts booklet.indd 5
8/2/2016 1:25:03 PM
DISCLOSURE STATEMENTS
SPEAKERS:
Joseph Bavaria, MD, has no relevant financial relationships.
Michael Deeb, MD, has no relevant financial relationships.
Felix Fernandez, MD, has no relevant financial relationships.
Richard Groom, CCP, has no relevant financial relationships.
Colleen Gruenwald, RN, PhD, has a relevant financial relationship as
a consultant with Medtronic Corp.
Benjamin Kozower, MD, has no relevant financial relationships.
Donald Likosky, PhD, has a relevant financial relationship as a
principal investigator with grant/research support from
Dartmouth College and AHRQ.
Michael Moront, MD, has a relevant financial relationship as a
consultant with Medtronic Corp,. and is on Medtronic’s speaker’s
bureau and is a principal investigator with grant/research support.
Mark Orringer, MD, has no relevant financial relationships.
Richard Prager, MD, has no relevant financial relationships.
Rishindra Reddy, MD, has a relevant financial relationship with
Intuitive as he is on the speaker’s bureau at Intuitive.
Alan Speir, MD, has a relevant financial relationship as a consultant
on the cardiac surgery advisory board with Medtronic Corp.
Glenn Whitman MD, has no relevant financial relationships.
Richard Whyte, MD, has no relevant financial relationships.
PLANNERS: listed Below have no relevant financial relationships.
Gail Bell, RN
Alonso Collar, MD
Richard L. Prager, MD
Patty Theurer, RN
Cindy Wikstrom
Jaelene Williams, RN
6
mscvts booklet.indd 6
8/2/2016 1:25:03 PM
HISTORY & LEADERSHIP
mscvts booklet.indd 7
8/2/2016 1:25:05 PM
A Brief History of the MSTCVS
By: Allen Silbergleit, M.D., Ph.D., F.A.C.S.
MSMS Delegate/Historian
From its inception, the mission of the Society has been to promote the highest standards of practice among
the relatively small number of certified thoracic surgeons in the state. An important adjunct of the primary
mission was to bring together all of the certified thoracic surgeons on a statewide basis to form a cohesive
group and single voice to face the rapidly changing socio-economic issues of the times.
The Michigan Society of Thoracic and Cardiovascular Surgeons (MSTCVS) began life as the Michigan
Society of Thoracic Surgeons (MSTS) in 1965, an era that saw the establishment of many national,
regional and state specialty societies. General medical associations, the American Medical Association and
many state and county societies had been in existence since the nineteenth century and from the begining
of the era of specialty societies, there had frequently been a relationship to the older general medical
groups.
Indeed, the first meeting of the MSTS in Detroit on September 21, 1965 was held in conjunction with and
on the occasion of the centennial meeting of the Michigan State Medical Society (MSMS). The meeting was
attended by 17 of the 60 board certified thoracic surgeons in Michigan at the time. The Constitution and
Bylaws of the Society were written by Dr. Raymond Barrett, the first Secretary-Treasurer, and accepted
by the membership. Dr. Cameron Haight was the first President.
The original intent of the MSTS was to hold an annual meeting in association with the annual meeting of
the MSMS and this was the case for the first 14 years. In the meantime, the Michigan Chapter of the
American College of Surgeons (MCACS) attracted the attention of several state surgical specialty societies
who considered it appropriate to meet in conjunction with the annual meeting of the umbrella surgical
group in the state. This arrangement functioned from 1979 until 1986, when the first meeting of the MSTS
took place without an affiliated group. A decision was made at that time to hold every annual meeting in the
summer and generally in northern Michigan, away from the hustle and bustle of the major population areas
in southern Michigan and the problem of members being called away from the meeting by their offices.
From the beginning, the annual meeting featured outstanding guest speakers including some of the most
prominent thoracic surgeons in the nation and the world. In 1970, an added feature to the scientific
program was the presentations by MSTS members and this has utilized variably in various formats. Another
feature was added in 1991, when a keynote speaker for the meeting was designated to honor a member of
the Society distinguished in the specialty and in service to the Society. This lecture is generally given as a
concluding event of the program. A resident competition was added to the program in 1992, providing a
format for residents in thoracic surgery, general surgery, peripheral vascular surgery and pediatric surgery
to compete for awards.
8
mscvts booklet.indd 8
8/2/2016 1:25:05 PM
The competition was in abeyance for several years but then resumed as a highly important feature of the
Society’s annual program. In recent years, there has usually been an interesting and entertaining speaker,
usually a surgeon of national renown, selected as the “Luncheon Speaker.”
As cardiovascular surgery had for a few decades assumed an increasingly prominent role in thoracic
surgery, the council and membership considered it appropriate to reflect this in the name of the
organization, although the new name would be slightly longer and more cumbersome. The Bylaws were
revised in 1988 changing the name of the organization from the MSTS to the MSTCVS.
The Society, with well over 100 members currently, was incorporated as a non-profit corporation in 1992.
This necessitated another revision of the Bylaws, approved by the membership at the annual meeting held
on August 8, 1992 on Drummond Island.
A major recent endeavor of the Society is the Quality Assurance initiative that has taken solid form. This
historic move reflects the commitment to quality that this Society has made to our patients and the State of
Michigan. The intent of the program is to see that nothing less than the very best care possible in the sphere
of thoracic and cardiovascular surgery is provided to every person in Michigan.
The summer sessions held in northern Michigan are programs of national quality, and have added considerably
to the annual meetings, which have become family affairs with spouses and children present, enjoying
northern Michigan in the summer and attending an evening family dinner. Members of the Society get to
know one another and their families during this congenial get-together. The mission of the Society is
fulfilled while providing a substantial number of category 1 CME credits for a first-rate program in a
casual and comfortable setting.
“From the beginning,
the annual meeting
featured outstanding
guest speakers including
some of the most prominent
thoracic surgeons in the
nation and the world.”
-Allen Silbergleit, M.D., Ph.D., F.A.C.S.
9
mscvts booklet.indd 9
8/2/2016 1:25:05 PM
Michigan Society of
Thoracic & Cardiovascular Surgeons
presents the
Sir Magdi Yacoub Lecture &
Rodman Taber Lecture
The Sir Magdi Yacoub lecture is awarded to a distinguished speaker who has been
responsible for major innovations in our specialty.
The lecture is named in honor of Sir Magdi Yacoub
who is a lifetime member of MSTCVS.
Sir Magdi Yacoub has received many honors including appointment to the
Order of Merit by H.M. Queen Elizabeth II.
Last year it was presented by Michael Mack, MD, Plano, TX.
2016 Sir Magdi Yacoub Lecture
Future of Cardiothoracic and Vascular Surgery
Friday the 12th at 11:15am to 12:00pm
Joseph Bavaria, MD, Philadelphia, PA
The Rodman Taber lecture is named in honor of our past-president and long
standing Board member, Rodman Taber, MD
This lectureship is awarded to a distinguished speaker who has made major
contributions to Cardiothoracic Surgery.
Last year it was presented by Randolph Chitwood, MD, Greenville, NC.
2016 Rodman Taber Lecture
Contemporary Ethical Issues in Cardiothoracic Surgery
Saturday the 13th at 11:00am to 11:45am
Richard Whyte, MD, Boston, MA
10
mscvts booklet.indd 10
8/2/2016 1:25:05 PM
Michigan Society of
Thoracic and Cardiovascular
Surgeons
Summer Meeting Agenda: August 11-14, 2016
THURSDAY, AUGUST 11th
9:00am - 9:55am
Data Manager Registration Mountain Grand Lodge Lobby
9:00am - 9:55am
Data Manager Continental Breakfast Vienna B
10:00am - 4:00pm
MSTCVS Quality Collaborative Cardiac Data Manager Meeting Vienna A
10:00am - 4:00pm
MSTCVS Quality Collaborative General Thoracic Data Manager Meeting Graz A
12:00pm - 1:00pm
Lunch: Data Managers Vienna B
12:00pm - 8:00pm
MSTCVS Registration Civic Center West Lobby
Reminder - sign in daily at the MSTCVS Registration Desk
4:30pm - 6:30pm
MSTCVS Quality Committee Meeting Vienna B
(Committee Member Surgeons Only)
Richard Prager, MD, Ann Arbor, MI
6:00pm -7:00pm
Welcome Reception – All Meeting Attendees Vienna Patio
7:00pm - 10:00pm
MSTCVS Quality Collaborative Meeting Matterhorn CD
Moderator: Richard Prager, MD, Ann Arbor, MI
7:00pm – 7:30pm
7:30pm – 8:00pm
8:00pm – 8:30pm 8:30pm – 9:00pm 9:00pm – 10:00pm MSTCVS Updates
Ten Years of POCMA
Patient Reported Outcomes
Felix Fernandez, MD, Atlanta, GA
MSTCVS Site Visit Report
TAVR POCMA
11
mscvts booklet.indd 11
8/2/2016 1:25:05 PM
Michigan Society of
Thoracic and Cardiovascular
Surgeons
Summer Meeting Agenda: August 11-14, 2016
FRIDAY, AUGUST 12th
6:30am - 4:00pm
MSTCVS Registration Civic Center West Lobby
Reminder - sign in daily at the MSTCVS Registration Desk
6:30am - 7:55am
Breakfast with Exhibitors Matterhorn AB
8:05am - 8:10am
Welcome Matterhorn CD
Alonso Collar, MD, MSTCVS President, Lansing, MI
Mini Aortic Symposium Matterhorn CD
8:10am - 8:40am
Current Therapy for Type A and B Aortic Dissection
Joseph Bavaria, MD, Philadelphia, PA
8:40am - 9:10am
TAVR in 2016
Michael Deeb, MD, Ann Arbor, MI
9:10am - 9:40am
Minimally Invasive Aortic Valve Surgery
Michael Moront, MD, Toledo, OH
9:40am - 10:00am
Panel Discussion
10:00am - 10:30am
Break with Exhibitors Matterhorn AB
Please take a moment to visit each exhibitor and thank them for their support
10:30am - 11:15am
Public Reporting of Surgical Outcomes Matterhorn CD
Benjamin Kozower, MD, MPH, St. Louis, MO
11:15am - 12:00pm
2016 Sir Magdi Yacoub Lecture Matterhorn CD
Future of Cardiothoracic and Vascular Surgery
Joseph Bavaria, MD, Philadelphia, PA
12:00pm - 1:15pm
Lunch Matterhorn CD
Alternate Payment Models
Alan Speir, MD, Falls Church, VA
1:15pm - 4:00pm
MSTCVS Quality Collaborative Meeting Matterhorn CD
Moderator: Richard Prager, MD, Ann Arbor, MI
1:15pm – 2:30pm
2:30pm – 3:00pm
3:00pm – 4:00pm
4:00pm - 6:00pm
6:00pm - 10:00pm
General Thoracic Data Review
STS General Thoracic Workforce Database Update
Benjamin Kozower, MD, MPH, St. Louis, MO
Cardiac Surgical AVR/TAVR and Aortic Procedure Data Review
Free Time for Family Activities
MSTCVS Annual Banquet & Entertainment Vienna
ENTERTAINMENT: PiP the COMIC ILLUSIONIST
see next page for all the details on this amazing entertainer!!!
12
mscvts booklet.indd 12
8/2/2016 1:25:08 PM
FRIDAY NIGHT
FROM 6-10 PM
is the MSTCVS ANNUAL BANQUET
FEATURING
PiP the COMIC ILLUSIONIST
In 2014 PiP Comic Illusionist, was a finalist on
Australia’s Got Talent 2012.
Classified as an ‘ALIEN WITH EXTRAORDINARY ABILITY’
he is a must see act!!
Now based in Las Vegas Nevada he showcases
his critically acclaimed sell out shows are pushing the
art form of magic, thanks to the unique and eccentric style
of illusions he creates.
His tours have included sold out shows
during the Adelaide Fringe, Sydney Comedy Festival,
Melbourne International Comedy Festival,
Melbourne Magic Festival
& at major venues including
the iconic Sydney Opera House.
More recently he has been seen in Las Vegas
at the Hard Rock Hotel & Casino,
The Cosmopolitan,
The Downtown Grand Hotel & Casino
& Playboy parties at The Palms.
Please note that 1 ticket is included with your registration.
To purchase additional tickets, please see the MSTCVS Registration Desk.
13
mscvts booklet.indd 13
8/2/2016 1:25:08 PM
Michigan Society of
Thoracic and Cardiovascular
Surgeons
Summer Meeting Agenda: August 11-14, 2016
SATURDAY, AUGUST 13th
6:45am - 4:00pm
MSTCVS Registration Civic Center West Lobby
Reminder - sign in daily at the MSTCVS Registration Desk
7:00am- 7:55am
Pneumonia Prevention Meeting Aurora
Donald Likosky, PhD, Ann Arbor, MI
6:30am - 7:55am
Breakfast with Exhibitors Matterhorn AB
8:05am - 8:15am
Welcome Matterhorn CD
Alonso Collar, MD, MSTCVS President, Lansing, Ml
8:15am - 9:00am
Critical Care Management of Cardiovascular Patients Matterhorn CD
Glenn Whitman, MD, Baltimore, MD
9:00am - 9:30am
Quality Measurement and Quality Improvement in Lung Cancer Surgery Matterhorn CD
Felix Fernandez, MD, MSC, Atlanta, GA
9:30am - 10:00am
Robotic Lobectomy: Technical Tips and Pitfalls Matterhorn CD
Rishindra Reddy, MD, Ann Arbor, MI
10:00am - 10:30am
Break with Exhibitors Matterhorn AB
Please take a moment to visit each exhibitor and thank them for their support
10:30am - 11:00am GERD and Hiatal Hernias: Old Principles Still Matter Matterhorn CD
Mark Orringer, MD, Ann Arbor, MI
11:00am - 11:45am 2016 Rodman Taber Lecture Matterhorn CD
Contemporary Ethical Issues in Cardiothoracic Surgery
Richard Whyte, MD, Boston, MA
12:00pm - 1:00pm
Lunch with Exhibitors Matterhorn AB
1:00pm - 1:30pm Resident Paper Session Matterhorn CD
Moderator: Allen Silbergleit, MD, Pontiac, MI
1:30pm - 4:00pm
MSTCVS Quality Collaborative Meeting Matterhorn CD
Moderator: Richard Prager, MD, Ann Arbor, MI
1:30pm – 2:30pm
2:30pm – 3:00pm
3:00pm – 3:30pm
3:30pm – 3:45pm
3:45pm – 4:00pm
4:00pm
MSTCVS CAB and Mitral Data
Goal Directed Perfusion
Robert Groom, CCP, MS Portland, ME
Pneumonia Prevention Panel
Case Presentation
Meeting Wrap up and Evaluation
Free Time for Family Activities
SUNDAY, AUGUST 14th
7:30am - 8:30am
MSTCVS Surgeon Breakfast Business Meeting with Election Results Vienna B
7:30am - 10:30am
MSTCVS/ MI Perfusion Society Breakfast Meeting Vienna A
mscvts booklet.indd 14
14
8/2/2016 1:25:11 PM
Exhibitors List & Booth Diagram
COMPANY........................................... BOOTH #
Abiomed, Inc........................................................................ 1
Astute Medical, Inc............................................................ 26
Atricure, Inc........................................................................... 3
CyroLife................................................................................ 8
Edwards Lifesciences........................................................ 14
Essential Pharmaceuticals.................................................. 5
Ethicon................................................................................. 12
General Cardiac Technology........................................... 6
Gore & Associates............................................................ 21
Grifols................................................................................. 20
HeartWare, Inc.................................................................... 7
KLS Martin............................................................................ 9
LivaNova............................................................................... 4
LSI Solutions........................................................................ 19
Mallinckrodt Pharmaceuticals......................................... 10
Maquet Medical Systems................................................ 18
MassMutal Michigan Metro............................................. 11
Medtronic (Heart valves, Revascularization, Ablation, & Perfusion).............17
Medtronic (INVOS, BIS)......................................................................................... 22
Medtronic AST (Stapling, Energy, Endomechanical.....................................24
Myriad Genetics, Inc........................................................ 28
Quest Medical..................................................................... 2
RTI Surgical, Inc................................................................. 27
DePuy Synthes................................................................... 23
St. Jude Medical............................................................... 13
Terumo Cardiovascular Group....................................... 15
The Medicines Company.................................................. 16
Exhibitor Hours
Friday, August 12th, 2016 from 6:30am to 4:30pm
Saturday, August 13th , 2016 from 7:00am to 4:00pm
Exhibit Hall: Matterhorn AB
mscvts booklet.indd 15
15
8/2/2016 1:25:11 PM
NOTES
16
mscvts booklet.indd 16
8/2/2016 1:25:11 PM
NOTES
17
mscvts booklet.indd 17
8/2/2016 1:25:11 PM
2016 SPEAKERS
mscvts booklet.indd 18
8/2/2016 1:25:12 PM
Joseph Bavaria, MD
Dr. Joseph Bavaria is currently the Brooke Roberts-William M. Measey Professor
of Surgery and Vice-Chief, Division of Cardiovascular Surgery at the Hospital of
the University of Pennsylvania. He is President-Elect of The Society of Thoracic
Surgeons. He is Director of the Thoracic Aortic Surgery Program at PENN which
is a multidisciplinary program encompassing all aspects of aortic disease
including thoracic aortic reconstruction and Marfan’s Syndrome. His primary
interests include thoracic aortic surgery and more broadly, Cardio-Aortic
surgery. This includes aortic dissection, aortic root and ascending aortic
reconstruction, aortic arch surgery and the circulation management necessary for
successful aortic arch clinical outcomes. Additionally, Dr. Bavaria’s clinical
interests include thoracoabdominal aortic aneurysm surgery and a very busy
program in the field of thoracic aortic endovascular stent grafting (TEVAR).
G. MICHAEL DEEB, M.D.
Early on at Temple University Hospital as Asst. Professor of Surgery
establishing their heart and lung transplantation program. In 1986 moved to the
University of Michigan as Director of the Heart Transplant Program. He was the
first surgeon to successfully perform a heart/lung transplant, single & double
lung transplant and insert a total artificial heart and an implantable mechanical
assist device in Michigan. 1990-became director of the Adult Cardiac Surgery
Service at the U of M Medical Center. 1991-promoted to an Associate
Professor. 1995-Established the aortic program at U of M. 1996-promoted
to Professor, appointed the Director of the Multidisciplinary Aortic Clinic and
Co-Director of the Heart Care Program at U of M. 2004-he is the first Herbert
Sloan Collegiate Professor of Cardiac Surgery. 2006-The University of
Pittsburgh Dept. of Chemistry Alumni Award. 2007-U of M Medical School
Dean’s Award for Outstanding Clinician. 2008-Forest Dewey Dodrill Award for
Excellence, Outstanding Clinician American Heart Association. 2012-Inducted
by U of M into the League of Clinical Excellence. 2014-he was awarded The
Mark B. Orringer Thoracic Surgery Teaching Award from U of M. 2015-Coeur
D’Or Award of Excellence by the American Heart Association in Detroit, MI.
Felix G. Fernandez, MD, MSc
Felix G. Fernandez, MD, MSc, is an Associate Professor of Surgery at Emory
University School of Medicine
Wayne State University School of Medicine 2000
General surgery and cardiothoracic surgery training at Barnes Jewish
Hospital completed in 2009
Clinical focus on thoracic oncology and academic focus on health services
research.
19
mscvts booklet.indd 19
8/2/2016 1:25:13 PM
Benjamin D. Kozower, MD, MPH
Benjamin D. Kozower, MD, MPH is a Professor of Surgery in the Division of
Cardiothoracic Surgery. He practiced for 10 years at the University of
Virginia and joined the faculty at Washington University in St. Louis this
August. Dr. Kozower completed his undergraduate and medical degrees from
the University of Rochester. He completed his general surgery training at the
University of Connecticut and his thoracic surgery residency at Washington
University School of Medicine in St. Louis, MO. His postdoctoral studies
include a thoracic surgery research fellowship at Washington University and a
Master of Public Health degree from the University of Virginia. For leisure,
Dr. Kozower enjoys hiking and cooking.
Donald Likosky, PhD
Dr. Likosky is an Associate Professor in the Department of Cardiac Surgery at
the University of Michigan, where is serves as the Section Head for Health
Services Research and Quality. He is also a faculty member at the Center for
Healthcare Outcomes and Policy. Dr. Likosky has held leadership positions within
a number of quality improvement collaboratives, including the Associate Director
for the Northern New England Cardiovascular Disease Study Group, and
epidemiologist for the Vascular Study Group of New England. He is the
Director of the International Consortium for Evidence-Based Perfusion (ICEBP),
a partnership and collaboration between perfusion societies, medical societies,
clinicians and industry to improve continuously the delivery of care and outcomes
for cardiac surgical patients. He is the co-founder and the Research Director for
the PERFusion Measures and outcomes (PERForm) registry, a cardiovascular
perfusion registry.
Michael Moront, MD
A native of Upstate New York, Dr. Moront graduated from Boston College
Magna Cum Laude-Phi Beta Kappa with studies in biochemistry and economics
and then attended Georgetown University School of Medicine where he
received his Medical degree and was selected into Alpha Omega Alpha
Medical Honor Society. Dr. Moront continued on at Georgetown Medical
Center and completed a General Surgery Residency and a year of Research as
an American Heart Association Fellow concentrating on Neonatal Exacorporeal
Membrane Oxygenation.
Dr. Moront received his Cardiac Surgical training, including a year of Pediatric
Cardiac Surgical training, at the University of Alabama at Birmingham.
Currently, Dr. Moront serves as the Director of Cardiac Surgical Research and
the Surgical Director of the Structural Hearth Team for Toledo Hospital and
Promedica Health System.
20
mscvts booklet.indd 20
8/2/2016 1:25:14 PM
Mark B. Orringer, MD
Mark B. Orringer, MD, is the Cameron Haight Distinguished University Professor
of Thoracic Surgery at the University of Michigan. He was a Phi Beta Kappa
graduate of the University of Pittsburgh undergraduate school in 1963 and an
Alpha Omega Alpha graduate of the University of Pittsburgh Medical School in
1967. He completed his general surgery and thoracic surgery residency training
at The Johns Hopkins Hospital in 1973. During his surgery residency, while at the
Frenchay Hospital in Bristol, England under the mentorship of Mr. Ronald Belsey,
he gained additional exposure tothe field of general thoracic surgery,
particularly the surgical treatment of esophageal disease.
As one of the country’s current leaders in the field of thoracic surgery, Dr.
Orringer has focused much of his academic career on the diagnosis and treatment
of benign and malignant esophageal disease. He has developed two leading
esophageal operations: the transhiatal esophagectomy without thoracotomy and
the combined Collis-Nissen hiatal hernia repair.
Rishindra reddy, MD
Rishindra M. Reddy, MD, was born and raised in Michigan. He earned his
undergraduate and medical degrees at Northwestern University, and
completed his general surgery residency at Washington University-Barnes Jewish
Hospital in St.Louis, Missouri. His spent two years during his residency, as a
Clinical Research Fellow at the National Cancer Institute in Bethesda,
Maryland. He completed his Thoracic Surgery residency at the University of
Washington and was a visiting fellow at Memorial Sloan Kettering Cancer
Center in New York. Dr. Reddy’s clinical interests include all aspects of
general thoracic surgery including thoracic oncology, minimally invasive
techniques, pectus repair and therapy for end-stage lung disease including
transplantation and lung volume reduction surgery. His academic interests
include improving outcomes for patients with thoracic cancers, molecular
targeting for thoracic cancers, resident and medical student education.
Richard L. Prager, MD
After training in General Surgery and Thoracic Surgery at the University of
Michigan, Dr. Prager began his cardiac and thoracic surgical career at
Vanderbilt University as an Assistant Professor in the Department of Cardiac
and Thoracic Surgery returning to Ann Arbor in 1983 to join the Cardiac and
Thoracic Surgical Group at St. Joseph Mercy Hospital. Dr. Prager was the
Medical Director of the HCFA Demonstration Project at St. Joseph Mercy
Hospital and the Head of the Section of Cardiac and Thoracic Surgery. In 1999,
he moved to University of Michigan as a Professor of Surgery and Head,
Section of Adult Cardiac Surgery.
Dr. Prager leads the Michigan Society of Thoracic and Cardiovascular Surgeons
Quality Collaborative Initiative and is a Director of the University of Michigan’s
Frankel Cardiovascular Center. He is the President of the Society of Thoracic
Surgeons and past President of the Southern Thoracic Surgical Association. In
July, 2016 he stepped down as Section Head of Adult Cardiac Surgery and
Associate Program Director of the Thoracic Surgery Fellowship and the
Integrated Cardiac and Thoracic Surgical residency.
mscvts booklet.indd 21
21
8/2/2016 1:25:14 PM
Alan M. Speir, MD
Alan M. Speir, MD has been a practicing cardiothoracic surgeon in the
metropolitan Washington, DC area for 34 years and is currently the Medical
Director of Cardiac Surgery for the Inova Health System. He has considerable
expertise and interest in quality improvement and cost containment in health
care and is a recognized national leader in developing alternative delivery and
payment models to improve patient care and lower costs. Speir was
instrumental in founding the Virginia Cardiac Surgery Quality Initiative (VCSQI)
in 1993 and now serves as Chairman of this statewide quality organization,
which includes 17 hospitals and 12 cardiac surgical practices performing over
99 percent of the cardiac surgery in the Commonwealth of Virginia. The
primary goal of the VCSQI is to improve outcomes and reduce costs in cardiac
surgery by process improvement, and to foster collaboration among all
programs via data sharing, process change, and improved efficiency.
Richard Whyte, MD
Richard Whyte, MD, is a native of the United Kingdom but grew up in Pittsburgh, PA. Richard Whyte attended The University of Pittsburgh for his
undergraduate degree and medical school. Completed his internship and
residency in General Surgery at Massachusetts General Hospital (1983-1990).
Thoracic surgical residency at University of Michigan (1990-1992). John
Alexander Fellowship at UM in 1993, then faculty (Assistant Professor) through
1997. Stanford University from 1997- 2011 initially as Chief of Thoracic
Surgery, then Vice-Chair of the Department of Cardiothoracic Surgery.
Appointed as Associate Professor in 1997 and promoted to (full) Professor in
2003. Obtained MBA from Wharton School in 2006. Relocated to Boston as
Vice-Chair of Surgery at Beth Israel Deaconess with appointment as Professor at
Harvard Medical School in 2011.
Glen Whitman, MD
Dr. Whitman is the Associate Professor of Surgery and the Director of the CVSICU and Heart Transplant program at Johns Hopkins. He previously served as the
Chief of Cardiac Surgery at the Medical College of Pennsylvania, as well as the
University of Maryland. His current focus at Hopkins is on systems improvements
and quality assurance in Cardiac Surgery Critical Care. Among all of his areas
of interest,teaching is foremost. He has received the golden apple and golden
scalpel awards on several occasions.
22
mscvts booklet.indd 22
8/2/2016 1:25:15 PM
2016 RESIDENTS
mscvts booklet.indd 23
8/2/2016 1:25:15 PM
Non-thrombogenic Coating
in Extracorporeal Circulation
Using Nitric Oxide Releasing Materials
BY AZMATH MOHAMMED, MD
INTRODUCTION: Cardiopulmonary Bypass (CPB) and Extracorporeal Membrane Oxygenation (ECMO)
are two types of lifesaving procedures that involve extracorporeal circulation (ECC) of flow of blood through
devices. One challenging aspect of ECC is requirement of systemic anticoagulation with its associated high risk of
major bleeding (3-36%). In order to circumvent systemic heparinization, non-thrombogenic surfaces coated with
heparin or hydrophilic molecules bound to inner surface have been developed without major success as systemic
heparinization is still required. Nitric oxide (NO) is a known potent inhibitor of platelet activation and adhesion
and it is released from healthy endothelial cells. We investigate embedding argatroban and NO
releasing materials (S-nitroso-N-acetylpenicillamine, SNAP and diazeniumdiolate dibutyl hexanediamine, DBHD)
into a CarboSil® polymer which creates a smooth coating inside ECC devices therefore minimizing thrombosis.
METHODS: Twenty-four New Zealand white rabbits were used for our studies. Following induction of
anesthesia, tracheostomy and placement of hemodynamic monitoring lines, an arteriovenous shunt was created
by cannulating the left carotid artery and right external jugular vein. This circuit was made of 3/8” ID Tygon®
poly(vinyl chloride) tubing. Six groups were studied: (1) control circuits (n=4) without coating, (2) SNAP in
CarboSil® polymer circuits (n=4) with the addition of white light-emitting diodes (L.E.D.), (3) SNAP in
CarboSil® polymer circuits (n=4) with copper, (4) DBHD in CarboSil® polymer circuits (n=4), (5) DBHD in Ca
rboSil® polymer circuits (n=4) with argatroban coating, (6) systemic heparin with no coating (n=4). Coated ECC
circuits were tested for 4hr in rabbits without systemic anticoagulation. Systemic hemodynamics, ECC blood flow,
and blood samples were collected at baseline, and hourly intervals. End-point parameters included
thrombus area, plasma fibrinogen levels, platelet count, and platelet function tests via aggregometry. At the end
of the study, ECC circuits were clamped, removed from animals, and gently rinsed with 60 mL of normal saline
(0.9%). Residual thrombus was photographed and quantitated. Comparison between groups was analyzed by a
comparison of means using student’s t-test.
RESULTS: Figure 1 illustrates circuit thrombus area for each group. Circuits coated with DBHD/argatroban had
the least thrombus area while control group was fully clotted. Initial circuit blood flow rates in all groups were
between 54-80mL/min. Platelet counts were preserved in SNAP and DBHD circuits while control circuit showed
significant decline (Figure 2). Platelet function tests using aggregometry showed significant decline in platelet
function in control circuits compared to SNAP and DBHD circuits (Figure 3).
CONCLUSION: This study demonstrates that circuits coated with nitric oxide releasing materials (SNAP and
DBHD) in a 4 hour rabbit model of extracorporeal circulation has decreased thrombus formation without the use
of systemic anticoagulation. Attempts to maximize NO release from the coatings by increasing L.E.D. intensity
and copper did not yield clot reduction. Additionally, circuits were coated with a second layer of direct thrombin
inhibitor (argatroban)attenuated clot formation by inhibiting the coagulation cascade. Long term rabbit and sheep
models are currently being tested to assess efficacy of our combined non-thrombogenic surface
coatings.
SEE FIGURES ON NEXT PAGE
24
mscvts booklet.indd 24
8/2/2016 1:25:15 PM
Figure 1: Circuit Thrombus Area
Figure 2: Platelet Counts During 4hr Circuit Time
Figure 3: Platelet Aggregation % During 4hr Circuit Time
mscvts booklet.indd 25
25
8/2/2016 1:25:16 PM
Efficacy of Transcutaneous Cerebral Oximetry
Monitoring During Carotid
Endarterectomy
BY Jeorge WEBER, MD
OBJECTIVES: Disease of the internal carotid artery is estimated to account for 15-20% of ischemic strokes. No
standard exists for intraoperative monitoring of cerebral perfusion during carotid endarterectomy (CEA). The
purpose of this pilot study was to monitor the adequacy of cerebral oxygenation as a result of cerebral blood flow
using the NONIN Sensmart Cerebral Oximeter in patients undergoing CEA and analyze trends in data that could
alert to earlier signs of inadequate perfusion.
METHODS: Patients were selected based on current recommendations for CEA. 51 consecutive patients
undergoing CEA were monitored using a NONIN Sensmart Oximetry device. Data was recorded at defined
intervals. Repeated measures ANOVA was performed to assess potential differences in oximetry on the ipsilateral
side as the procedure at baseline, clamping of carotid artery, shunt placement, and extubation. PROC GLM in SAS
9.4 was used to perform all analyses, and a significance level of α = 0.05 was used for significance. Patients deemed
to have had “intraoperative cerebral events” were further analyzed.
RESULTS: 51 patients were included in the analysis. The average baseline value on the ipsilateral side was 69.1%.
After shunt placement, the value increased by an average of 3.38 units (95% CI 1.19-5.58, P= <0.0001). The average
oximetry value at the time of carotid clamping was 2.3 units higher than at the time of shunt placement (95% CI
0.11-4.5, P= 0.0401). When comparing extubation values to those at baseline, there was an average of a 10.78 unit
increase in value (95% CI 8.60-12.96, P= <0.0001). No difference existed comparing baseline values with those at
the time of clamping (P=0.314). Two patients were selected out based on observed adverse clinical outcome. The
first patient had oximetry values lower than expected after flow was restored had CT evidence of ischemia. The
second patient suffered profound hypotension intraoperatively as a consequence of Protamine administration.
CONCLUSIONS: Patients who undergo carotid endarterectomy are at risk for developing intra-operative
complications related to inadequate cerebral flow. Though no standard exists and surgeon preference dictates
practice, the NONIN Sensmart Oximeter has shown promise as an adjunct and tool that could alert the surgeon
to early signs of inadequate perfusion.
26
mscvts booklet.indd 26
8/2/2016 1:25:16 PM
Thoracic EndoVascular Aortic Repair
for Symptomatic and Ruptured Aneurysms
and Penetrating Ulcers
BY Peter BEAULIEU, MD
BACKGROUND: In large multicenter studies, the clinical outcomes of Thoracic EndoVascular Aortic Repair
(TEVAR) for traumatic tears are superior to open repair. TEVAR can also be considered for a variety of other acute
pathologies of the thoracic aorta.
HYPOTHESIS: TEVAR for ruptured thoracic aortic aneurysms, intramural hematoma or penetrating ulcers is
safe with good intermediate survival.
DESIGN: Retrospective review of our TEVAR database.
SETTING: Large urban tertiary referral medical center.
PATIENTS AND METHODS: The clinical presentation and diagnostic studies of patients presenting for
urgent or emergent TEVAR were reviewed. Operative details, complications, short and long-term outcomes were
reviewed. We excluded all patients undergoing emergent TEVAR for traumatic tears.
RESULTS: In a 8-year period ending in May 2015, we found 28 patients subjected to urgent/emergent TEVAR;
group A included 16 (9 females) for penetrating ulcers or intramural hematoma and group B had 12 (5 females)
for ruptured throacic aneurysms. Iliac or aortic conduits were constructed to deliver the endograft in 3 patients
in group A and 4 in group B. One patient in each group required a snorkel to protect an important side branch
(celiac, left carotid). There were no acute myocardial infarctions or postoperative paraplegias. Average follow-up
was 3 years. One patient in each group died. One patient in group B returned 3 years later with a type I endoleak
and was reoperated. Overall, there were no significant differences between groups and excellent mid-term survival
and freedom from re-intervention were achieved.
CONCLUSION: Emergent TEVAR for ruptured thoracic aneurysms, penetrating ulcers and intramural
hematomas is safe with reasonable short and intermediate term outcomes in selected patients.
27
mscvts booklet.indd 27
8/2/2016 1:25:16 PM
MSTCVS would like to extend a warm
thank you to all our amazing exhibitors
At HeartWare, we are focused on innovation and enhancing outcomes in the treatment of
end stage heart failure. With the rising utilization of the HVAD® System in the market,
it has quickly become the VAD of choice, demonstrating high survival rates,
low complication rates and improved quality of life.
mscvts booklet.indd 28
8/2/2016 1:25:16 PM
MSTCVS would like to extend a warm
thank you to all our amazing exhibitors
Innovation. It’s at the heart of what we do.
Hoopless End Effector
Small Diameter End Effector (12 mm)
Active Articulation Levers
A Simplified Approach to LAA Exclusion
AtriClip PRO2™
Device
Enhanced Flexibility
Uniform Lesion
Engineered for Performance
Flexibility Desired, Consistency Needed
Probe
See what we do at our MSTCVS Booth
Rx Only
Indications: cryoFORM: The cryoICE® cryoablation probes are indicated for use in the cryosurgical treatment of cardiac arrhythmias. AtriClip PRO2: The AtriClip® Left Atrial Appendage (LAA)
Exclusion System is indicated for the occlusion of the LAA, under direct visualization, in conjunction with other open cardiac surgical procedures.
MKT-2038B-G
mscvts booklet.indd 29
www.atricure.com
8/2/2016 1:25:18 PM
MSTCVS would like to extend a warm
thank you to all our amazing exhibitors
mscvts booklet.indd 30
8/2/2016 1:25:19 PM
MSTCVS would like to extend a warm
thank you to all our amazing exhibitors
mscvts booklet.indd 31
8/2/2016 1:25:21 PM
MSTCVS would like to extend a warm
thank you to all our amazing exhibitors
Jeff Morgan
St. Jude Medical
A
SPECIAL
THANK YOU
TO OUR
GOLD
SPONSORS
mscvts booklet.indd 32
8/2/2016 1:25:22 PM
MSTCVS would like to extend a warm
thank you to all our amazing exhibitors
mscvts booklet.indd 33
8/2/2016 1:25:23 PM
MSTCVS would like to extend a warm
thank you to all our amazing exhibitors
mscvts booklet.indd 34
8/2/2016 1:25:23 PM
mscvts booklet.indd 35
8/2/2016 1:25:24 PM
Save
Save the
the Date
Date
2017
2017 MSTCVS
MSTCVS
Annual
Annual Summer
Summer Meeting
Meeting
July
July 27th-July
27th-July 30th,
30th, 2017
2017
at
at The
The Grand
Grand Traverse
Traverse Resort
Resort
le a r n MORE AT w w w. M S TC V S.OR G
T he Michig a n S o ciet y
of T hor a cic & C ardio va s cul a r
Surgeo ns
mscvts booklet.indd 36
8/2/2016 1:25:25 PM